Oncoverity, Inc.
Clinical trials sponsored by Oncoverity, Inc., explained in plain language.
-
New drug combo targets Hard-to-Treat leukemia
Disease control OngoingThis early-phase study tests a new drug called cusatuzumab, given alongside usual treatments, for adults with acute myeloid leukemia (AML) who cannot have strong chemotherapy. The main goal is to check the safety and side effects of this combination. About 61 participants will re…
Phase: PHASE1 • Sponsor: OncoVerity, Inc. • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New hope for AML patients: triple drug combo tested in phase 2 trial
Disease control OngoingThis study tests whether adding the experimental drug cusatuzumab to two standard AML medications (venetoclax and azacitidine) helps people with newly diagnosed AML live longer. The trial includes 140 adults who cannot receive intensive chemotherapy. Researchers will compare surv…
Phase: PHASE2 • Sponsor: OncoVerity, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC